Lilly's weight loss pill Foundayo passes heart safety test in largest diabetes trial yet

The once-daily GLP-1 pill cut blood sugar more than insulin and shed 17.9 pounds on average — Lilly plans to file for FDA diabetes approval by end of Q2

Go to News Site